For the millions who survive dengue fever annually, recovery may not fully restore cellular integrity — a possibility that has profound implications for understanding post-infectious syndromes and long-term disease burden. New molecular evidence now points to a specific mechanism: dengue virus actively disrupts the host cell's ability to maintain and repair its own DNA.
Research published in the Proceedings of the National Academy of Sciences examined how dengue virus serotype 4 (DENV-4) alters host gene expression, with particular focus on DNA damage response pathways. The findings reveal that DENV-4 infection suppresses transcription of key DNA repair genes, effectively silencing the molecular machinery cells rely on to correct genomic errors. This transcriptional repression promotes genome instability — a state in which chromosomal integrity deteriorates and mutations accumulate. The study situates this mechanism within the broader context of dengue's known capacity to trigger post-dengue syndromes, conditions that persist well beyond the acute febrile phase and remain poorly understood clinically.
This finding carries meaningful implications beyond the acute infection window. Genome instability is not a benign bystander — it is a hallmark of cancer initiation, accelerated cellular aging, and chronic inflammatory disease. If dengue-induced suppression of DNA repair is durable rather than transient, it could help explain why post-dengue fatigue, neurological complications, and other sequelae linger for months. This positions dengue less as a self-limiting illness and more as a potential contributor to longer-term cellular dysfunction. The study is mechanistic in nature, and critical questions remain: whether these transcriptional changes reverse upon viral clearance, whether they occur equivalently across all four serotypes, and whether human clinical cohorts replicate the molecular picture. Still, identifying a specific transcriptional suppression mechanism is a meaningful step toward developing targeted interventions for post-dengue pathology.